Academic and Clinical Excellence
The Vermont Center for Immunobiology and Infectious Diseases (VCIID) was created in 2006 with a five-year $11.4 million Phase I Center for Biological Research Excellence (COBRE) grant from the National Institutes of Health and National Institute of General Medical Sciences. In 2011, we entered a second five-year Phase II period. VCIID combines the expertise of the UVM groups in Immunobiology, Microbiology, Infectious Diseases, and the Vermont Vaccine Trials Center to promote collaborative studies into the immune response to infectious agents, including viruses, bacteria and parasites, as well as studies of microbial pathogenesis and autoimmune disorders.
The Center includes UVM faculty in eight departments and three colleges. VCIID has an NIH T32 Training Grant to support graduate students and a collaboration with the Trudeau Institute in Saranac Lake, NY, with whom we have shared a PO1 Program Project Grant. We also maintain an active seminar series that brings international investigators in immunology and microbiology. In addition, we are committed to an expansion of the Center through the recruitment of new faculty.
A research training program in Immunology and Infectious Diseases exists with opportunities for undergraduate and graduate students and postdoctoral fellows. This is supported by funds from both the COBRE and T32 Training Grant awards.
The Center supports core facilities in microarray, bioinformatics, proteomics, and flow cytometry. Clinical Trials for Infectious Dieases are conducted with the Division of Infectious Diseases and Vermont Vaccine Testing Center, and for autoimmune and rheumatic diseases with the Division of Rheumatology and Clinical Immunology.
Last modified June 29 2015 11:13 AM